Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes.
Nieuwlaat
Robby
R
Connolly
Stuart J
SJ
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D004812:Epidemiologic Methods; D006801:Humans; D020521:Stroke / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome
D000925:Anticoagulants